Document_And_Entity_Informatio
Document And Entity Information | 9 Months Ended | |
Dec. 31, 2013 | Jan. 28, 2014 | |
Document And Entity Information [Abstract] | ' | ' |
Document Type | '10-Q | ' |
Amendment Flag | 'false | ' |
Document Period End Date | 31-Dec-13 | ' |
Document Fiscal Period Focus | 'Q3 | ' |
Document Fiscal Year Focus | '2014 | ' |
Entity Registrant Name | 'UQM TECHNOLOGIES INC | ' |
Entity Central Index Key | '0000315449 | ' |
Current Fiscal Year End Date | '--03-31 | ' |
Entity Filer Category | 'Non-accelerated Filer | ' |
Entity Common Stock, Shares Outstanding | ' | 37,548,959 |
Consolidated_Balance_Sheets
Consolidated Balance Sheets (USD $) | Dec. 31, 2013 | Mar. 31, 2013 |
Assets | ' | ' |
Cash and cash equivalents | $6,263,510 | $4,527,899 |
Accounts receivable, net of allowance for doubtful accounts of zero and $3,838,092, respectively | 682,980 | 2,212,395 |
Costs and estimated earnings in excess of billings on uncompleted contracts | 445,037 | 178,264 |
Inventories | 10,255,074 | 10,998,461 |
Facility held for sale | ' | 1,525,000 |
Prepaid expenses and other current assets | 304,417 | 309,957 |
Total current assets | 17,951,018 | 19,751,976 |
Property and equipment, at cost: | ' | ' |
Land | 1,683,330 | 1,683,330 |
Building | 4,516,301 | 4,516,301 |
Machinery and equipment | 8,208,689 | 7,771,363 |
Property, plant and equipment, gross | 14,408,320 | 13,970,994 |
Less accumulated depreciation | -6,348,064 | -5,507,801 |
Net property and equipment | 8,060,256 | 8,463,193 |
Patent costs, net of accumulated amortization of $872,118 and $845,795, respectively | 227,339 | 206,287 |
Trademark costs, net of accumulated amortization of $67,595 and $64,230, respectively | 107,163 | 110,528 |
Other assets | 65,880 | 76,731 |
Total assets | 26,411,656 | 28,608,715 |
Liabilities and Stockholders' Equity | ' | ' |
Accounts payable | 551,701 | 617,197 |
Other current liabilities | 1,666,114 | 2,599,435 |
Short-term deferred compensation under executive employment agreements | ' | 524,000 |
Total current liabilities | 2,217,815 | 3,740,632 |
Long-term deferred compensation under executive employment agreements | 162,165 | 103,412 |
Total liabilities | 2,379,980 | 3,844,044 |
Commitments and contingencies | ' | ' |
Stockholders' equity: | ' | ' |
Common stock, $.01 par value, 50,000,000 shares authorized; 36,891,654 and 36,664,097 shares issued and outstanding | 368,917 | 366,641 |
Additional paid-in capital | 116,232,596 | 115,573,331 |
Accumulated deficit | -92,569,837 | -91,175,301 |
Total stockholders' equity | 24,031,676 | 24,764,671 |
Total liabilities and stockholders' equity | $26,411,656 | $28,608,715 |
Consolidated_Balance_Sheets_Pa
Consolidated Balance Sheets (Parenthetical) (USD $) | Dec. 31, 2013 | Mar. 31, 2013 |
Consolidated Balance Sheets [Abstract] | ' | ' |
Allowance for Doubtful Accounts Receivable | $0 | $3,838,092 |
Patent costs, accumulated amortization | 872,118 | 845,795 |
Trademark costs, accumulated amortization | $67,595 | $64,230 |
Common stock, par value per share | $0.01 | $0.01 |
Common stock, shares authorized | 50,000,000 | 50,000,000 |
Common stock, shares issued | 36,891,654 | 36,664,097 |
Common Stock, Shares, Outstanding | 36,891,654 | 36,664,097 |
Consolidated_Statements_Of_Ope
Consolidated Statements Of Operations (USD $) | 3 Months Ended | 9 Months Ended | ||
Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2013 | Dec. 31, 2012 | |
Revenue: | ' | ' | ' | ' |
Product sales | $1,825,351 | $1,692,276 | $5,351,287 | $4,568,795 |
Contract services | 214,898 | 235,794 | 679,431 | 951,807 |
Total Revenues | 2,040,249 | 1,928,070 | 6,030,718 | 5,520,602 |
Operating costs and expenses: | ' | ' | ' | ' |
Costs of product sales | 1,053,716 | 1,529,852 | 3,134,230 | 3,331,469 |
Costs of contract services | 153,647 | 121,624 | 552,797 | 518,159 |
Research and development | 44,307 | 23,190 | 158,852 | 55,647 |
Production engineering | 818,460 | 991,653 | 2,851,416 | 3,646,975 |
Reimbursement of costs under DOE grant | -451,026 | -1,446,356 | -2,576,685 | -3,176,556 |
Selling, general and administrative | 1,220,184 | 1,434,241 | 4,079,660 | 5,729,741 |
Impairment of assets under supply agreement | -726,640 | 3,833,860 | -726,640 | 3,833,860 |
(Gain) loss on disposal of long-lived assets | ' | 407 | -40,032 | 407 |
Total Costs and Expenses | 2,112,648 | 6,488,471 | 7,433,598 | 13,939,702 |
Loss before other income | -72,399 | -4,560,401 | -1,402,880 | -8,419,100 |
Other income: | ' | ' | ' | ' |
Interest income | 339 | 5,244 | 1,409 | 10,250 |
Other | 6,147 | 124 | 6,935 | 2,835 |
Total nonoperating income | 6,486 | 5,368 | 8,344 | 13,085 |
Net loss | ($65,913) | ($4,555,033) | ($1,394,536) | ($8,406,015) |
Net loss per common share - basic and diluted | $0 | ($0.12) | ($0.04) | ($0.23) |
Weighted average number of shares of common stock outstanding - basic and diluted | 36,878,092 | 36,654,737 | 36,794,834 | 36,532,510 |
Consolidated_Statements_Of_Cas
Consolidated Statements Of Cash Flows (USD $) | 9 Months Ended | |
Dec. 31, 2013 | Dec. 31, 2012 | |
Cash flows from operating activities: | ' | ' |
Net loss | ($1,394,536) | ($8,406,015) |
Adjustments to reconcile net loss to net cash used in operating activities: | ' | ' |
Depreciation and amortization | 869,951 | 986,029 |
Impairment of assets under supply agreement | -726,640 | 3,833,860 |
(Gain) loss on disposal of long-lived assets | -40,032 | 407 |
Non-cash equity based compensation | 610,716 | 1,020,740 |
Change in operating assets and liabilities: | ' | ' |
Accounts receivable and costs and estimated earnings in excess of billings on uncompleted contracts | 1,246,490 | -523,607 |
Inventories | 743,387 | -2,198,745 |
Prepaid expenses and other current assets | 5,540 | 12,793 |
Accounts payable and other current liabilities | -272,177 | -709,770 |
Billings in excess of costs and estimated earnings on uncompleted contracts | ' | 78,584 |
Deferred compensation under executive employment agreements | -465,247 | -100,186 |
Net cash used in operating activities | 577,452 | -6,005,910 |
Cash flows from investing activities: | ' | ' |
Purchases of short-term investments | -447 | -245,950 |
Maturities of short-term investments | ' | 728,859 |
Increase in other long-term assets | ' | -437 |
Acquisition of property and equipment | -840,331 | -392,850 |
Property and equipment reimbursements received from DOE under grant | 430,455 | 170,289 |
Cash proceeds from sale of facility held for sale | 1,565,032 | ' |
Increase in patent and trademark costs | -47,375 | -21,704 |
Net cash provided by investing activities | 1,107,334 | 238,207 |
Cash flows from financing activities: | ' | ' |
Issuance of common stock under employee stock purchase plan | 39,438 | 75,178 |
Issuance of common stock upon exercise of employee stock options | 11,387 | ' |
Purchase of treasury stock | ' | -40,430 |
Net cash provided by financing activities | 50,825 | 34,748 |
Increase (decrease) in cash and cash equivalents | 1,735,611 | -5,732,955 |
Cash and cash equivalents at beginning of period | 4,527,899 | 11,637,940 |
Cash and cash equivalents at end of period | $6,263,510 | $5,904,985 |
Basis_Of_Presentation
Basis Of Presentation | 9 Months Ended |
Dec. 31, 2013 | |
Basis Of Presentation [Abstract] | ' |
Basis Of Presentation | ' |
(1) The accompanying consolidated condensed financial statements are unaudited; however, in the opinion of management, all adjustments necessary for a fair presentation of the results for the interim periods have been made. The results for the interim periods are not necessarily indicative of the results to be expected for the fiscal year. The Notes contained herein should be read in conjunction with the Notes to our Consolidated Financial Statements filed on Form 10-K for the year ended March 31, 2013. | |
New_Accounting_Pronouncements
New Accounting Pronouncements | 9 Months Ended |
Dec. 31, 2013 | |
New Accounting Pronouncements | ' |
New Accounting Pronouncements | ' |
(2) New Accounting Pronouncements | |
As of December 31, 2013, there were no new accounting pronouncements expected to significantly impact our consolidated financial statements, results of operations, or cash flows. | |
Contracts_In_Process
Contracts In Process | 9 Months Ended | ||||||
Dec. 31, 2013 | |||||||
Contracts In Process [Abstract] | ' | ||||||
Contracts In Process | ' | ||||||
(3) At December 31, 2013 and March 31, 2013, the estimated period to complete contracts in process ranged from one to thirteen months and one to twenty-one months, respectively. We expect to collect all related accounts receivable arising from these contracts within sixty days of billing. The following summarizes contracts in process: | |||||||
31-Dec-13 | 31-Mar-13 | ||||||
Costs incurred on uncompleted contracts | $ | 1,366,709 | $ | 838,246 | |||
Estimated earnings | 636,517 | 515,299 | |||||
2,003,226 | 1,353,545 | ||||||
Less billings to date | -1,558,189 | -1,175,281 | |||||
Costs and estimated earnings in excess of billings on | |||||||
uncompleted contracts | $ | 445,037 | $ | 178,264 | |||
Inventories
Inventories | 9 Months Ended | ||||||
Dec. 31, 2013 | |||||||
Inventories [Abstract] | ' | ||||||
Inventories | ' | ||||||
(4) Inventories at December 31, 2013 and March 31, 2013 consisted of: | |||||||
31-Dec-13 | 31-Mar-13 | ||||||
Raw materials | $ | 7,697,141 | $ | 8,097,342 | |||
Work-in-process | 126,976 | 356,696 | |||||
Finished products | 2,430,957 | 2,544,423 | |||||
$ | 10,255,074 | $ | 10,998,461 | ||||
Our inventories are subject to obsolescence and potential impairment due to bulk purchases in excess of customers’ requirements. We periodically assess our inventories for recovery of carrying value based on available information, expectations and estimates, and adjust inventory carrying values to the lower of cost or market for estimated declines in the realizable value. There was no impairment for obsolete inventory during the nine month periods ended December 31, 2013 and 2012. | |||||||
Facility_Held_For_Sale
Facility Held For Sale | 9 Months Ended |
Dec. 31, 2013 | |
Facility Held For Sale [Abstract] | ' |
Facility Held For Sale | ' |
(5) Facility Held for Sale | |
We had listed our former facility in Frederick, Colorado for sale with a commercial real estate broker as of March 31, 2013. The facility was reclassified as a current asset and we had discontinued depreciating the asset pending the sale of the building. | |
On June 6, 2013, we closed on the sale the building. The sales price was $1,650,000 and net proceeds were $1,565,032. | |
Government_Grants
Government Grants | 9 Months Ended | |||||||||
Dec. 31, 2013 | ||||||||||
Government Grants [Abstract] | ' | |||||||||
Government Grants | ' | |||||||||
(6) Government Grant | ||||||||||
We have a grant (the “Grant”) with the U.S. Department of Energy (“DOE”) under the American Recovery and Reinvestment Act for reimbursements up to a maximum of $32.4 million. The Grant provides funds to facilitate the manufacture and deployment of electric drive vehicles, batteries and electric drive vehicle components in the United States. Pursuant to the terms of the Agreement, the DOE will reimburse us for 50 percent of qualifying costs for the purchase of facilities, tooling and manufacturing equipment, and for engineering related to product qualification and testing of our electric propulsion systems. The period of the Grant is through January 12, 2015. We recognize government grant reimbursements when it is probable that the Company will comply with the conditions attached to the grant arrangement and the grant money will be received. | ||||||||||
The Grant is also subject to our compliance with certain reporting requirements. The American Recovery and Reinvestment Act imposes minimum construction wages and labor standards for projects funded by the Grant. | ||||||||||
If we dispose of assets acquired using Grant funding, we may be required to reimburse the DOE upon such sale date if the fair value of the asset on the date of disposition exceeds $5,000. The amount of any such reimbursement shall be equal to 50 percent of the fair value of the asset on the date of disposition. | ||||||||||
While UQM has exclusive patent ownership rights for any technology developed with Grant funds, we are required to grant the DOE a non-exclusive, non-transferable, paid-up license to use such technology. | ||||||||||
During the second quarter of the current fiscal year, we changed our cumulative estimate of reimbursable rates under the Grant which resulted in an increase in our reimbursement of costs recorded for the nine month period ended December 31, 2013 of $958,000. At December 31, 2013, we had received reimbursements from the DOE under the Grant totaling $24.0 million and had funds receivable under the Grant of $0.2 million. | ||||||||||
The application of grant funds to the recorded value of eligible capital asset purchases under the Grant as of December 31, 2013 and March 31, 2013 are as follows: | ||||||||||
31-Dec-13 | ||||||||||
Purchase Cost | Grant Funding | Recorded Value | ||||||||
Land | $ | 896,388 | $ | 448,194 | $ | 448,194 | ||||
Building | 9,906,736 | 4,953,368 | 4,953,368 | |||||||
Machinery and Equipment | 8,410,016 | 4,205,008 | 4,205,008 | |||||||
$ | 19,213,140 | $ | 9,606,570 | $ | 9,606,570 | |||||
31-Mar-13 | ||||||||||
Purchase Cost | Grant Funding | Recorded Value | ||||||||
Land | $ | 896,388 | $ | 448,194 | $ | 448,194 | ||||
Building | 9,906,736 | 4,953,368 | 4,953,368 | |||||||
Machinery and Equipment | 7,581,408 | 3,790,704 | 3,790,704 | |||||||
$ | 18,384,532 | $ | 9,192,266 | $ | 9,192,266 | |||||
Other_Current_Liabilities
Other Current Liabilities | 9 Months Ended | ||||||
Dec. 31, 2013 | |||||||
Other Current Liabilities [Abstract] | ' | ||||||
Other Current Liabilities | ' | ||||||
(7) Other current liabilities at December 31, 2013 and March 31, 2013 consist of: | |||||||
31-Dec-13 | 31-Mar-13 | ||||||
Accrued payroll and employee benefits | $ | 64,024 | $ | 174,135 | |||
Accrued personal property and real estate taxes | 313,243 | 264,814 | |||||
Accrued warranty costs | 168,587 | 77,393 | |||||
Unearned revenue | 60,512 | 71,442 | |||||
Accrued royalties | 48,336 | 48,336 | |||||
Accrued import duties | 87,100 | 813,740 | |||||
Accrued vendor settlements | 916,809 | 1,050,000 | |||||
Other | 7,503 | 99,575 | |||||
$ | 1,666,114 | $ | 2,599,435 | ||||
In the third quarter of fiscal year 2013, we recorded a liability of $813,740 to accrue for potential import duties for products purchased from China. We appealed to the Department of Commerce and sought to have the duty fees reduced. In December, 2013, the Department of Commerce issued a ruling that significantly reduced the amount of duties owed. Therefore, in the quarter ended December 31, 2013, we reduced our accrual for import duties by $726,640 to $87,100 reflecting the amount now owed. | |||||||
StockBased_Compensation
Stock-Based Compensation | 9 Months Ended | ||||||||||||
Dec. 31, 2013 | |||||||||||||
Stock-Based Compensation [Abstract] | ' | ||||||||||||
Stock-Based Compensation | ' | ||||||||||||
(8) Stock-Based Compensation | |||||||||||||
Stock Option Plans | |||||||||||||
As of December 31, 2013, we had 1,100,000 shares of common stock authorized and 14,870 shares of common stock available for future grant to employees and consultants under our 2012 Equity Incentive Plan (“Plan”). The term of the 2012 Plan is ten years. Under the 2012 Plan, the exercise price of each option is set at the fair value of the common stock on the date of grant and the maximum term of the option is ten years from the date of grant. Options granted to employees generally have a ten year term and vest ratably over a three-year period. The maximum number of options that may be granted to an employee under the Plan in any calendar year is 500,000 options. Forfeitures under the Plan are available for re-issuance at any time prior to expiration of the Plan in 2022. Options granted under the Plan to employees require the option holder to abide by certain Company policies, which restrict their ability to sell the underlying common stock. Prior to the adoption of the 2012 Plan, we issued stock options under our 2002 Equity Incentive Plan. Forfeitures under the 2002 Equity Incentive Plan may not be re-issued. | |||||||||||||
We also have a Stock Option Plan for Non-Employee Directors (“Directors Plan”) pursuant to which Directors may elect to receive stock options in lieu of cash compensation for their services as directors. As of December 31, 2013, we had 1,000,000 shares of common stock authorized and 224,173 shares of common stock available for future grant under the Directors Plan. Option terms range from three to ten years from the date of grant. Option exercise prices are equal to the fair value of the common shares on the date of grant. Options granted under the plan vest immediately. Forfeitures under the Directors Plan are available for re-issuance at a future date. | |||||||||||||
Stock Bonus Plan | |||||||||||||
We have a Stock Bonus Plan (“Stock Plan”) administered by the Board of Directors. As of December 31, 2013, we had 1,954,994 shares of common stock authorized and there were 47,149 shares of common stock available for future grant under the Stock Plan. Under the Stock Plan, shares of common stock may be granted to employees, key consultants, and directors who are not employees as additional compensation for services rendered. Vesting requirements for grants under the Stock Plan, if any, are determined by the Board of Directors at the time of grant. | |||||||||||||
Stock Purchase Plan | |||||||||||||
We have established a Stock Purchase Plan under which eligible employees may contribute up to 10 percent of their compensation to purchase shares of our common stock at 85 percent of the fair market value at specified dates. At December 31, 2013, we had 700,000 shares of common stock authorized and 321,539 shares of common stock available for issuance under the Stock Purchase Plan. | |||||||||||||
Share-Based Compensation Expense | |||||||||||||
We use the straight-line attribution method to recognize share-based compensation costs over the requisite service period of the award. The exercise price of options is equal to the market price of our common stock (defined as the closing price reported by the NYSE MKT) on the date of grant. We adjust share-based compensation on a quarterly basis for changes to the estimate of expected equity award forfeitures based on actual forfeiture experience. The effect of adjusting the forfeiture rate for all expense amortization is recognized in the period the forfeiture estimate is changed. The effect of forfeiture adjustments in the quarters and nine month periods ended December 31, 2013 and 2012 were insignificant. | |||||||||||||
We use the Black-Scholes-Merton option pricing model for estimating the fair value of stock option awards. The expected volatility and the expected life of options granted are based on historical experience, and the risk free interest rate is obtained from the U.S. Department of the Treasury daily yield curve rates. There were no stock options granted during the quarter ended December 31, 2013. The weighted average estimated values of employee and director stock option grants, as well as the weighted average assumptions that were used in calculating such values during the quarter ended December 31, 2012 and the nine month periods ended December 31, 2013 and 2012, were based on estimates at the date of grant as follows: | |||||||||||||
Quarter Ended | |||||||||||||
December 31, | Nine Months Ended December 31, | ||||||||||||
2012 | 2013 | 2012 | |||||||||||
Weighted average estimated | |||||||||||||
fair value of grant | $ | 0.43 | $ | 0.67 | $ | 0.56 | |||||||
Expected life (in years) | 2.5 | 4.8 | 6.3 | ||||||||||
Risk free interest rate | 0.73 | % | 2.30 | % | 1.30 | % | |||||||
Expected volatility | 81.85 | % | 73.91 | % | 72.80 | % | |||||||
Expected dividend yield | 0.00 | % | 0.00 | % | 0.00 | % | |||||||
The table below shows total share-based compensation expense for the quarters and nine month periods ended December 31, 2013 and 2012 and the classification of these expenses: | |||||||||||||
Quarter Ended December 31, | Nine Months Ended December 31, | ||||||||||||
2013 | 2012 | 2013 | 2012 | ||||||||||
Costs of contract services | $ | 3,647 | $ | 6,062 | $ | 15,712 | $ | 16,362 | |||||
Costs of product sales | 10,565 | 13,492 | 30,883 | 35,329 | |||||||||
Research and development | 4,282 | 846 | 7,544 | 2,152 | |||||||||
Production engineering | 30,659 | 35,765 | 103,007 | 114,360 | |||||||||
Selling, general and administrative | 123,487 | 163,898 | 453,570 | 852,537 | |||||||||
$ | 172,640 | $ | 220,063 | $ | 610,716 | $ | 1,020,740 | ||||||
Share-based compensation capitalized in inventories was insignificant as of December 31, 2013 and March 31, 2013. | |||||||||||||
Stock Option Plans Activity | |||||||||||||
Additional information with respect to stock option activity during the nine month period ended December 31, 2013 under our Stock Option Plans is as follows: | |||||||||||||
Weighted- | |||||||||||||
Weighted- | Average | ||||||||||||
Shares | Average | Remaining | Aggregate | ||||||||||
Under | Exercise | Contractual | Intrinsic | ||||||||||
Option | Price | Life | Value | ||||||||||
Outstanding at April 1, 2013 | 4,251,695 | $ | 2.14 | 4.7 years | $ | - | |||||||
Granted | 89,340 | $ | 1.11 | ||||||||||
Exercised | -12,794 | $ | 0.89 | $ | 15,689 | ||||||||
Forfeited | -736,604 | $ | 2.69 | ||||||||||
Outstanding at December 31, 2013 | 3,591,637 | $ | 2.01 | 4.7 years | $ | 1,859,201 | |||||||
Exercisable at December 31, 2013 | 2,895,111 | $ | 2.23 | 3.9 years | $ | 1,102,526 | |||||||
Vested and expected to vest at December 31, 2013 | 3,555,224 | $ | 2.02 | 4.7 years | $ | 1,818,171 | |||||||
Additional information with respect to stock option activity during the nine month period ended December 31, 2012 under our Stock Option Plans is as follows: | |||||||||||||
Weighted- | |||||||||||||
Weighted- | Average | ||||||||||||
Shares | Average | Remaining | Aggregate | ||||||||||
Under | Exercise | Contractual | Intrinsic | ||||||||||
Option | Price | Life | Value | ||||||||||
Outstanding at April 1, 2012 | 3,228,210 | $ | 2.78 | 3.9 years | $ | - | |||||||
Granted | 1,418,792 | $ | 0.87 | ||||||||||
Exercised | - | $ | - | $ | - | ||||||||
Forfeited | -176,420 | $ | 2.97 | ||||||||||
Outstanding at December 31, 2012 | 4,470,582 | $ | 2.17 | 4.8 years | $ | - | |||||||
Exercisable at December 31, 2012 | 3,309,967 | $ | 2.50 | 3.3 years | $ | - | |||||||
Vested and expected to vest at December 31, 2012 | 4,413,233 | $ | 2.18 | 4.7 years | $ | - | |||||||
A summary of the status of non-vested shares under our Stock Option Plans as of December 31, 2013 and 2012 and changes during the nine month periods ended December 31, 2013 and 2012 are presented below: | |||||||||||||
Nine Months Ended December 31, 2013 | Nine Months Ended December 31, 2012 | ||||||||||||
Weighted-Average | Weighted-Average | ||||||||||||
Shares Under | Grant Date | Shares Under | Grant Date | ||||||||||
Option | Fair Value | Option | Fair Value | ||||||||||
Non-vested at April 1 | 1,152,828 | $ | 0.84 | 668,722 | $ | 1.69 | |||||||
Granted | 89,340 | $ | 0.68 | 1,418,792 | $ | 0.56 | |||||||
Vested | -533,380 | $ | 0.92 | -888,089 | $ | 1.00 | |||||||
Forfeited | -12,262 | $ | 0.84 | -38,810 | $ | 1.37 | |||||||
Non-vested at December 31 | 696,526 | $ | 0.75 | 1,160,615 | $ | 0.84 | |||||||
As of December 31, 2013, there was $351,378 of total unrecognized compensation costs related to stock options granted under our Stock Option Plans. The unrecognized compensation cost is expected to be recognized over a weighted-average period of seventeen months. The total fair value of stock options that vested during the quarter and nine month period ended December 31, 2013 was $9,333 and $493,271, respectively. The total fair value of stock options that vested during the quarter and nine month period ended December 31, 2012 was $77,058 and $885,916. | |||||||||||||
Cash received by us upon the exercise of stock options under our Stock Option Plans was $11,387 for the quarter and nine month period ended December 31, 2013 and zero for the quarter and nine month period ended December 31, 2012. The source of shares of common stock issuable upon the exercise of stock options is from authorized and previously unissued common shares | |||||||||||||
Stock Bonus Plan Activity | |||||||||||||
Activity with respect to non-vested shares under the Stock Bonus Plan as of December 31, 2013 and 2012 and changes during the nine month periods ended December 31, 2013 and 2012 are presented below: | |||||||||||||
Nine Months Ended December 31, 2013 | Nine Months Ended December 31, 2012 | ||||||||||||
Weighted-Average | Weighted-Average | ||||||||||||
Shares Under | Grant Date | Shares Under | Grant Date | ||||||||||
Contract | Fair Value | Contract | Fair Value | ||||||||||
Non-vested at April 1 | 358,855 | $ | 1.22 | 167,680 | $ | 2.44 | |||||||
Granted | 452,195 | $ | 1.18 | 454,866 | $ | 0.87 | |||||||
Vested | -166,231 | $ | 1.34 | -263,691 | $ | 1.39 | |||||||
Forfeited | -3,840 | $ | 1.25 | - | $ | - | |||||||
Non-vested at December 31 | 640,979 | $ | 1.17 | 358,855 | $ | 1.22 | |||||||
As of December 31, 2013, there was $571,609 of total unrecognized compensation costs related to common stock granted under our Stock Bonus Plan. The unrecognized compensation cost at December 31, 2013 is expected to be recognized over a weighted-average period of twenty-six months. | |||||||||||||
Stock Purchase Plan Activity | |||||||||||||
During the nine month periods ended December 31, 2013 and 2012, we issued 48,532 and 85,336 shares of common stock, respectively, under the Stock Purchase Plan. Cash received by us upon the purchase of shares under the Stock Purchase Plan for the nine month periods ended December 31, 2013 and 2012 was $39,438 and $75,178, respectively. | |||||||||||||
Stockholders_Equity
Stockholders' Equity | 9 Months Ended | |||||||||||||||
Dec. 31, 2013 | ||||||||||||||||
Stockholders' Equity [Abstract] | ' | |||||||||||||||
Stockholders' Equity | ' | |||||||||||||||
(9) Stockholders’ Equity | ||||||||||||||||
Changes in the components of stockholders’ equity during the quarters and nine month period ended December 31, 2013 were as follows: | ||||||||||||||||
Number of | ||||||||||||||||
common | Additional | Total | ||||||||||||||
shares | Common | paid-in | Accumulated | stockholders’ | ||||||||||||
issued | stock | capital | deficit | equity | ||||||||||||
Balances at April 1, 2013 | 36,664,097 | $ | 366,641 | $ | 115,573,331 | $ | -91,175,301 | $ | 24,764,671 | |||||||
Issuance of common stock under | ||||||||||||||||
employee stock purchase plan | 5,412 | 54 | 3,518 | - | 3,572 | |||||||||||
Compensation expense from | ||||||||||||||||
employee and director stock | ||||||||||||||||
option and common stock grants | - | - | 162,724 | - | 162,724 | |||||||||||
Net loss | - | - | - | -916,354 | -916,354 | |||||||||||
Balances at June 30, 2013 | 36,669,509 | $ | 366,695 | $ | 115,739,573 | $ | -92,091,655 | $ | 24,014,613 | |||||||
Issuance of common stock under | ||||||||||||||||
employee stock purchase plan | 28,618 | 286 | 17,743 | - | 18,029 | |||||||||||
Issuance of common stock under | ||||||||||||||||
stock bonus plan | 166,231 | 1,663 | 34,836 | - | 36,499 | |||||||||||
Compensation expense from | ||||||||||||||||
employee and director stock | ||||||||||||||||
option and common stock grants | - | - | 238,853 | - | 238,853 | |||||||||||
Net loss | - | - | - | -412,269 | -412,269 | |||||||||||
Balances at September 30, 2013 | 36,864,358 | $ | 368,644 | $ | 116,031,005 | $ | -92,503,924 | $ | 23,895,725 | |||||||
Issuance of common stock under | ||||||||||||||||
employee stock purchase plan | 14,502 | 145 | 17,692 | - | 17,837 | |||||||||||
Issuance of common stock upon | ||||||||||||||||
exercise of employee stock options | 12,794 | 128 | 11,259 | - | 11,387 | |||||||||||
Compensation expense from | ||||||||||||||||
employee and director stock | ||||||||||||||||
option and common stock grants | - | - | 172,640 | - | 172,640 | |||||||||||
Net loss | - | - | - | -65,913 | -65,913 | |||||||||||
Balances at December 31, 2013 | 36,891,654 | $ | 368,917 | $ | 116,232,596 | $ | -92,569,837 | $ | 24,031,676 | |||||||
Significant_Customers
Significant Customers | 9 Months Ended | ||||||||||||||||||||||||
Dec. 31, 2013 | |||||||||||||||||||||||||
Significant Customers [Abstract] | ' | ||||||||||||||||||||||||
Significant Customers | ' | ||||||||||||||||||||||||
(10) Significant Customers | |||||||||||||||||||||||||
We have historically derived significant revenue from a few key customers. The following table summarizes revenue and percent of total revenue from significant customers for the quarters and nine month periods ended December 31, 2013 and December 31, 2012: | |||||||||||||||||||||||||
Quarter Ended December 31, | Nine Months Ended December 31, | ||||||||||||||||||||||||
2013 | 2012 | 2013 | 2012 | ||||||||||||||||||||||
Customer A | $ | 189,968 | 9 | % | $ | 735,190 | 38 | % | $ | 652,632 | 11 | % | $ | 978,230 | 18 | % | |||||||||
Customer B | $ | 208,929 | 10 | % | $ | 31,370 | 2 | % | $ | 268,623 | 4 | % | $ | 62,740 | 1 | % | |||||||||
Customer C | $ | 214,898 | 11 | % | $ | 235,564 | 12 | % | $ | 649,681 | 11 | % | $ | 856,150 | 16 | % | |||||||||
The following table summarizes accounts receivable from significant customers as of December 31, 2013 and March 31, 2013: | |||||||||||||||||||||||||
31-Dec-13 | 31-Mar-13 | ||||||||||||||||||||||||
Customer A | - | % | 3 | % | |||||||||||||||||||||
Customer B | - | % | - | % | |||||||||||||||||||||
Customer C | 27 | % | 9 | % | |||||||||||||||||||||
Income_Taxes
Income Taxes | 9 Months Ended |
Dec. 31, 2013 | |
Income Taxes [Abstract] | ' |
Income Taxes | ' |
(11) Income Taxes | |
The Company currently has a full valuation allowance, as it is management’s judgment that it is more-likely-than-not that net deferred tax assets will not be realized to reduce future taxable income. | |
We recognize interest and penalties related to uncertain tax positions in “Other Income,” net. As of December 31, 2013 and 2012, we had no provisions for interest or penalties related to uncertain tax positions. | |
The tax years 2009 through 2012 remain open to examination by both the Internal Revenue Service of the United States and by the various state taxing authorities where we file. | |
Loss_Per_Common_Share
Loss Per Common Share | 9 Months Ended |
Dec. 31, 2013 | |
Loss Per Common Share [Abstract] | ' |
Loss Per Common Share | ' |
(12) Loss Per Common Share | |
Basic earnings per share is computed by dividing income or loss available to common stockholders by the weighted average number of common shares outstanding during the periods presented. Diluted earnings per share is computed by dividing income or loss available to common stockholders by all outstanding and potentially dilutive shares during the periods presented, unless the effect is antidilutive. At December 31, 2013 and 2012, respectively, common shares issued under the Stock Bonus Plan but not yet earned totaling 640,979 and 358,855 were being held by the Company. For the quarters and nine month periods ended December 31, 2013 and 2012 respectively, 213,943 and 34,793, and 92,779 and 26,519 shares, were potentially includable in the calculation of diluted loss per share under the treasury stock method but were not included, because to do so would be antidilutive. At December 31, 2013 and 2012, options to purchase 3,605,526 and 4,496,168 shares of common stock, respectively, were outstanding. For the quarters and nine month periods ended December 31, 2013 and 2012, respectively, options for 2,125,169 and 3,091,144 and 2,125,169 and 3,066,144 shares were not included in the computation of diluted loss per share because the option exercise price was greater than the average market price of the common stock. In-the-money options determined under the treasury stock method to acquire 768,662 and 198,847, and 497,477 and 144,379 shares of common stock for the quarters and nine month periods ended December 31, 2013 and 2012, respectively, were potentially includable in the calculation of diluted loss per share but were not, because to do so would be antidilutive. | |
Fair_Value_Of_Financial_Instru
Fair Value Of Financial Instruments | 9 Months Ended |
Dec. 31, 2013 | |
Fair Value Of Financial Instruments [Abstract] | ' |
Fair Value Of Financial Instruments | ' |
(13) Fair Value of Financial Instruments | |
The following methods and assumptions were used to estimate the fair value of each class of financial instruments. | |
Cash and cash equivalents: | |
The carrying amounts approximate fair value because of the short maturity of these instruments. | |
Fair_Value_Measurements
Fair Value Measurements | 9 Months Ended | ||||||||||||||
Dec. 31, 2013 | |||||||||||||||
Fair Value Measurements [Abstract] | ' | ||||||||||||||
Fair Value Measurements | ' | ||||||||||||||
(14) Fair Value Measurements | |||||||||||||||
Liabilities measured at fair value on a recurring basis as of December 31, 2013 are summarized below: | |||||||||||||||
Fair Value at Reporting Date Using | |||||||||||||||
Quoted Prices | |||||||||||||||
In Active | Significant | ||||||||||||||
Markets | Other | Significant | |||||||||||||
For Identical | Observable | Unobservable | |||||||||||||
Liabilities | Inputs | Inputs | |||||||||||||
Total | (Level 1) | (Level 2) | (Level 3) | ||||||||||||
Deferred compensation under | |||||||||||||||
executive employment agreements (1) | $ | 162,165 | - | - | $ | 162,165 | |||||||||
Note (1) Included in current liabilities on our consolidated condensed balance sheet as of December 31, 2013. | |||||||||||||||
Liabilities measured at fair value on a recurring basis as of March 31, 2013 are summarized below: | |||||||||||||||
Fair Value at Reporting Date Using | |||||||||||||||
Quoted Prices | |||||||||||||||
In Active | Significant | ||||||||||||||
Markets | Other | Significant | |||||||||||||
For Identical | Observable | Unobservable | |||||||||||||
Liabilities | Inputs | Inputs | |||||||||||||
Total | (Level 1) | (Level 2) | (Level 3) | ||||||||||||
Deferred compensation under | |||||||||||||||
executive employment agreements (1) | $ | 627,412 | - | - | $ | 627,412 | |||||||||
Note (1) $524,000 included in current liabilities and $103,412 included in long term liabilities on our consolidated condensed balance sheet as of March 31, 2013. | |||||||||||||||
Deferred compensation under executive employment agreements represents the future compensation potentially payable under the retirement and voluntary termination provisions of executive employment agreements. The value of the Level 3 liability in the foregoing table was determined using a discounted cash flow model. The significant unobservable input used in the calculation is a discount rate of 14 percent, which is based on the expected cost of capital for the Company. A 1 percent change in this discount rate would result in approximately a $2,000 change in the recorded value of the liability as of December 31, 2013. | |||||||||||||||
A summary of the liability measured at fair value on a recurring basis using significant unobservable inputs (Level 3) follows: | |||||||||||||||
Fair Value Measurements Using Significant | |||||||||||||||
Unobservable Inputs (Level 3) | |||||||||||||||
Deferred Compensation Under Executive Employment Agreements | |||||||||||||||
Quarter Ended December 31, | Nine Months Ended December 31, | ||||||||||||||
2013 | 2012 | 2013 | 2012 | ||||||||||||
Balance at beginning of period | $ | 666,229 | $ | 602,081 | $ | 627,412 | $ | 715,107 | |||||||
Transfers into Level 3 | - | - | - | - | |||||||||||
Transfers out of Level 3 | - | - | - | - | |||||||||||
Total gains or losses (realized and unrealized): | |||||||||||||||
Included in earnings | 19,936 | 12,840 | 58,753 | 51,821 | |||||||||||
Included in other comprehensive income | - | - | - | - | |||||||||||
Settlements | -524,000 | - | -524,000 | -152,007 | |||||||||||
Balance at the end of period | $ | 162,165 | $ | 614,921 | $ | 162,165 | $ | 614,921 | |||||||
Loss for the quarter included in earnings attributable | |||||||||||||||
to the Level 3 liability still held at the end of the period | $ | 19,936 | $ | 12,840 | $ | 58,753 | $ | 51,821 | |||||||
Commitments_And_Contingencies
Commitments And Contingencies | 9 Months Ended |
Dec. 31, 2013 | |
Commitments And Contingencies [Abstract] | ' |
Commitments And Contingencies | ' |
(15) Commitments and Contingencies | |
Employment Agreements | |
We have entered into employment agreements with five of our officers. Messrs. Ridenour, Rosenthal, Lutz, Schaffer and Mitchell have agreed to serve in their present capacity for a term expiring on August 31, 2015. The aggregate future base salary payable to these five executive officers under the employment agreements over their remaining terms is $1,908,167. In addition, we have recorded a liability of $162,165 and $627,412 at December 31, 2013 and March 31, 2013, respectively, representing the potential future compensation payable under the retirement and voluntary termination provisions of the employment agreements of the Company’s current and former officers. | |
Litigation | |
We are involved in various claims and legal actions arising in the ordinary course of business. In the opinion of management, and based on current available information, the ultimate disposition of these matters is not expected to have a material adverse effect on our financial position, results of operations or cash flow, although adverse developments in these matters could have a material impact on a future reporting period. | |
Contracts_In_Process_Tables
Contracts In Process (Tables) | 9 Months Ended | ||||||
Dec. 31, 2013 | |||||||
Contracts In Process [Abstract] | ' | ||||||
Summary Of Contract In Process | ' | ||||||
31-Dec-13 | 31-Mar-13 | ||||||
Costs incurred on uncompleted contracts | $ | 1,366,709 | $ | 838,246 | |||
Estimated earnings | 636,517 | 515,299 | |||||
2,003,226 | 1,353,545 | ||||||
Less billings to date | -1,558,189 | -1,175,281 | |||||
Costs and estimated earnings in excess of billings on | |||||||
uncompleted contracts | $ | 445,037 | $ | 178,264 | |||
Inventories_Tables
Inventories (Tables) | 9 Months Ended | ||||||
Dec. 31, 2013 | |||||||
Inventories [Abstract] | ' | ||||||
Schedule Of Inventories | ' | ||||||
31-Dec-13 | 31-Mar-13 | ||||||
Raw materials | $ | 7,697,141 | $ | 8,097,342 | |||
Work-in-process | 126,976 | 356,696 | |||||
Finished products | 2,430,957 | 2,544,423 | |||||
$ | 10,255,074 | $ | 10,998,461 | ||||
Government_Grants_Tables
Government Grants (Tables) | 9 Months Ended | |||||||||
Dec. 31, 2013 | ||||||||||
Government Grants [Abstract] | ' | |||||||||
Schedule Of Capital Asset Purchases, Partially Funded By Government Grants | ' | |||||||||
31-Dec-13 | ||||||||||
Purchase Cost | Grant Funding | Recorded Value | ||||||||
Land | $ | 896,388 | $ | 448,194 | $ | 448,194 | ||||
Building | 9,906,736 | 4,953,368 | 4,953,368 | |||||||
Machinery and Equipment | 8,410,016 | 4,205,008 | 4,205,008 | |||||||
$ | 19,213,140 | $ | 9,606,570 | $ | 9,606,570 | |||||
31-Mar-13 | ||||||||||
Purchase Cost | Grant Funding | Recorded Value | ||||||||
Land | $ | 896,388 | $ | 448,194 | $ | 448,194 | ||||
Building | 9,906,736 | 4,953,368 | 4,953,368 | |||||||
Machinery and Equipment | 7,581,408 | 3,790,704 | 3,790,704 | |||||||
$ | 18,384,532 | $ | 9,192,266 | $ | 9,192,266 | |||||
Other_Current_Liabilities_Tabl
Other Current Liabilities (Tables) | 9 Months Ended | ||||||
Dec. 31, 2013 | |||||||
Other Current Liabilities [Abstract] | ' | ||||||
Schedule Of Other Current Liabilities | ' | ||||||
31-Dec-13 | 31-Mar-13 | ||||||
Accrued payroll and employee benefits | $ | 64,024 | $ | 174,135 | |||
Accrued personal property and real estate taxes | 313,243 | 264,814 | |||||
Accrued warranty costs | 168,587 | 77,393 | |||||
Unearned revenue | 60,512 | 71,442 | |||||
Accrued royalties | 48,336 | 48,336 | |||||
Accrued import duties | 87,100 | 813,740 | |||||
Accrued vendor settlements | 916,809 | 1,050,000 | |||||
Other | 7,503 | 99,575 | |||||
$ | 1,666,114 | $ | 2,599,435 | ||||
StockBased_Compensation_Tables
Stock-Based Compensation (Tables) | 9 Months Ended | ||||||||||||
Dec. 31, 2013 | |||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ' | ||||||||||||
Schedule of Valuation Assumptions | ' | ||||||||||||
Quarter Ended | |||||||||||||
December 31, | Nine Months Ended December 31, | ||||||||||||
2012 | 2013 | 2012 | |||||||||||
Weighted average estimated | |||||||||||||
fair value of grant | $ | 0.43 | $ | 0.67 | $ | 0.56 | |||||||
Expected life (in years) | 2.5 | 4.8 | 6.3 | ||||||||||
Risk free interest rate | 0.73 | % | 2.30 | % | 1.30 | % | |||||||
Expected volatility | 81.85 | % | 73.91 | % | 72.80 | % | |||||||
Expected dividend yield | 0.00 | % | 0.00 | % | 0.00 | % | |||||||
Schedule Of Share-Based Compensation Expense | ' | ||||||||||||
Quarter Ended December 31, | Nine Months Ended December 31, | ||||||||||||
2013 | 2012 | 2013 | 2012 | ||||||||||
Costs of contract services | $ | 3,647 | $ | 6,062 | $ | 15,712 | $ | 16,362 | |||||
Costs of product sales | 10,565 | 13,492 | 30,883 | 35,329 | |||||||||
Research and development | 4,282 | 846 | 7,544 | 2,152 | |||||||||
Production engineering | 30,659 | 35,765 | 103,007 | 114,360 | |||||||||
Selling, general and administrative | 123,487 | 163,898 | 453,570 | 852,537 | |||||||||
$ | 172,640 | $ | 220,063 | $ | 610,716 | $ | 1,020,740 | ||||||
Equity Incentive Plan [Member] | ' | ||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ' | ||||||||||||
Schedule Of Nonvested Share Activity | ' | ||||||||||||
Nine Months Ended December 31, 2013 | Nine Months Ended December 31, 2012 | ||||||||||||
Weighted-Average | Weighted-Average | ||||||||||||
Shares Under | Grant Date | Shares Under | Grant Date | ||||||||||
Option | Fair Value | Option | Fair Value | ||||||||||
Non-vested at April 1 | 1,152,828 | $ | 0.84 | 668,722 | $ | 1.69 | |||||||
Granted | 89,340 | $ | 0.68 | 1,418,792 | $ | 0.56 | |||||||
Vested | -533,380 | $ | 0.92 | -888,089 | $ | 1.00 | |||||||
Forfeited | -12,262 | $ | 0.84 | -38,810 | $ | 1.37 | |||||||
Non-vested at December 31 | 696,526 | $ | 0.75 | 1,160,615 | $ | 0.84 | |||||||
Summary Of Stock Option Activity | ' | ||||||||||||
Additional information with respect to stock option activity during the nine month period ended December 31, 2013 under our Stock Option Plans is as follows: | |||||||||||||
Weighted- | |||||||||||||
Weighted- | Average | ||||||||||||
Shares | Average | Remaining | Aggregate | ||||||||||
Under | Exercise | Contractual | Intrinsic | ||||||||||
Option | Price | Life | Value | ||||||||||
Outstanding at April 1, 2013 | 4,251,695 | $ | 2.14 | 4.7 years | $ | - | |||||||
Granted | 89,340 | $ | 1.11 | ||||||||||
Exercised | -12,794 | $ | 0.89 | $ | 15,689 | ||||||||
Forfeited | -736,604 | $ | 2.69 | ||||||||||
Outstanding at December 31, 2013 | 3,591,637 | $ | 2.01 | 4.7 years | $ | 1,859,201 | |||||||
Exercisable at December 31, 2013 | 2,895,111 | $ | 2.23 | 3.9 years | $ | 1,102,526 | |||||||
Vested and expected to vest at December 31, 2013 | 3,555,224 | $ | 2.02 | 4.7 years | $ | 1,818,171 | |||||||
Additional information with respect to stock option activity during the nine month period ended December 31, 2012 under our Stock Option Plans is as follows: | |||||||||||||
Weighted- | |||||||||||||
Weighted- | Average | ||||||||||||
Shares | Average | Remaining | Aggregate | ||||||||||
Under | Exercise | Contractual | Intrinsic | ||||||||||
Option | Price | Life | Value | ||||||||||
Outstanding at April 1, 2012 | 3,228,210 | $ | 2.78 | 3.9 years | $ | - | |||||||
Granted | 1,418,792 | $ | 0.87 | ||||||||||
Exercised | - | $ | - | $ | - | ||||||||
Forfeited | -176,420 | $ | 2.97 | ||||||||||
Outstanding at December 31, 2012 | 4,470,582 | $ | 2.17 | 4.8 years | $ | - | |||||||
Exercisable at December 31, 2012 | 3,309,967 | $ | 2.50 | 3.3 years | $ | - | |||||||
Vested and expected to vest at December 31, 2012 | 4,413,233 | $ | 2.18 | 4.7 years | $ | - | |||||||
Stock Bonus Plan [Member] | ' | ||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ' | ||||||||||||
Schedule Of Nonvested Share Activity | ' | ||||||||||||
Nine Months Ended December 31, 2013 | Nine Months Ended December 31, 2012 | ||||||||||||
Weighted-Average | Weighted-Average | ||||||||||||
Shares Under | Grant Date | Shares Under | Grant Date | ||||||||||
Contract | Fair Value | Contract | Fair Value | ||||||||||
Non-vested at April 1 | 358,855 | $ | 1.22 | 167,680 | $ | 2.44 | |||||||
Granted | 452,195 | $ | 1.18 | 454,866 | $ | 0.87 | |||||||
Vested | -166,231 | $ | 1.34 | -263,691 | $ | 1.39 | |||||||
Forfeited | -3,840 | $ | 1.25 | - | $ | - | |||||||
Non-vested at December 31 | 640,979 | $ | 1.17 | 358,855 | $ | 1.22 | |||||||
Stockholders_Equity_Tables
Stockholders' Equity (Tables) | 9 Months Ended | |||||||||||||||
Dec. 31, 2013 | ||||||||||||||||
Stockholders' Equity [Abstract] | ' | |||||||||||||||
Changes In Components Of Stockholders' Equity | ' | |||||||||||||||
Number of | ||||||||||||||||
common | Additional | Total | ||||||||||||||
shares | Common | paid-in | Accumulated | stockholders’ | ||||||||||||
issued | stock | capital | deficit | equity | ||||||||||||
Balances at April 1, 2013 | 36,664,097 | $ | 366,641 | $ | 115,573,331 | $ | -91,175,301 | $ | 24,764,671 | |||||||
Issuance of common stock under | ||||||||||||||||
employee stock purchase plan | 5,412 | 54 | 3,518 | - | 3,572 | |||||||||||
Compensation expense from | ||||||||||||||||
employee and director stock | ||||||||||||||||
option and common stock grants | - | - | 162,724 | - | 162,724 | |||||||||||
Net loss | - | - | - | -916,354 | -916,354 | |||||||||||
Balances at June 30, 2013 | 36,669,509 | $ | 366,695 | $ | 115,739,573 | $ | -92,091,655 | $ | 24,014,613 | |||||||
Issuance of common stock under | ||||||||||||||||
employee stock purchase plan | 28,618 | 286 | 17,743 | - | 18,029 | |||||||||||
Issuance of common stock under | ||||||||||||||||
stock bonus plan | 166,231 | 1,663 | 34,836 | - | 36,499 | |||||||||||
Compensation expense from | ||||||||||||||||
employee and director stock | ||||||||||||||||
option and common stock grants | - | - | 238,853 | - | 238,853 | |||||||||||
Net loss | - | - | - | -412,269 | -412,269 | |||||||||||
Balances at September 30, 2013 | 36,864,358 | $ | 368,644 | $ | 116,031,005 | $ | -92,503,924 | $ | 23,895,725 | |||||||
Issuance of common stock under | ||||||||||||||||
employee stock purchase plan | 14,502 | 145 | 17,692 | - | 17,837 | |||||||||||
Issuance of common stock upon | ||||||||||||||||
exercise of employee stock options | 12,794 | 128 | 11,259 | - | 11,387 | |||||||||||
Compensation expense from | ||||||||||||||||
employee and director stock | ||||||||||||||||
option and common stock grants | - | - | 172,640 | - | 172,640 | |||||||||||
Net loss | - | - | - | -65,913 | -65,913 | |||||||||||
Balances at December 31, 2013 | 36,891,654 | $ | 368,917 | $ | 116,232,596 | $ | -92,569,837 | $ | 24,031,676 | |||||||
Significant_Customers_Tables
Significant Customers (Tables) | 9 Months Ended | ||||||||||||||||||||||||
Dec. 31, 2013 | |||||||||||||||||||||||||
Sales Revenue, Goods, Net [Member] | ' | ||||||||||||||||||||||||
Schedules of Concentration of Risk, by Risk Factor [Table Text Block] | ' | ||||||||||||||||||||||||
Quarter Ended December 31, | Nine Months Ended December 31, | ||||||||||||||||||||||||
2013 | 2012 | 2013 | 2012 | ||||||||||||||||||||||
Customer A | $ | 189,968 | 9 | % | $ | 735,190 | 38 | % | $ | 652,632 | 11 | % | $ | 978,230 | 18 | % | |||||||||
Customer B | $ | 208,929 | 10 | % | $ | 31,370 | 2 | % | $ | 268,623 | 4 | % | $ | 62,740 | 1 | % | |||||||||
Customer C | $ | 214,898 | 11 | % | $ | 235,564 | 12 | % | $ | 649,681 | 11 | % | $ | 856,150 | 16 | % | |||||||||
Accounts Receivable [Member] | ' | ||||||||||||||||||||||||
Schedules of Concentration of Risk, by Risk Factor [Table Text Block] | ' | ||||||||||||||||||||||||
31-Dec-13 | 31-Mar-13 | ||||||||||||||||||||||||
Customer A | - | % | 3 | % | |||||||||||||||||||||
Customer B | - | % | - | % | |||||||||||||||||||||
Customer C | 27 | % | 9 | % | |||||||||||||||||||||
Fair_Value_Measurements_Tables
Fair Value Measurements (Tables) | 9 Months Ended | ||||||||||||||
Dec. 31, 2013 | |||||||||||||||
Fair Value Measurements [Abstract] | ' | ||||||||||||||
Liabilities Measured At Fair Value On A Recurring Basis | ' | ||||||||||||||
Liabilities measured at fair value on a recurring basis as of December 31, 2013 are summarized below: | |||||||||||||||
Fair Value at Reporting Date Using | |||||||||||||||
Quoted Prices | |||||||||||||||
In Active | Significant | ||||||||||||||
Markets | Other | Significant | |||||||||||||
For Identical | Observable | Unobservable | |||||||||||||
Liabilities | Inputs | Inputs | |||||||||||||
Total | (Level 1) | (Level 2) | (Level 3) | ||||||||||||
Deferred compensation under | |||||||||||||||
executive employment agreements (1) | $ | 162,165 | - | - | $ | 162,165 | |||||||||
Note (1) Included in current liabilities on our consolidated condensed balance sheet as of December 31, 2013. | |||||||||||||||
Liabilities measured at fair value on a recurring basis as of March 31, 2013 are summarized below: | |||||||||||||||
Fair Value at Reporting Date Using | |||||||||||||||
Quoted Prices | |||||||||||||||
In Active | Significant | ||||||||||||||
Markets | Other | Significant | |||||||||||||
For Identical | Observable | Unobservable | |||||||||||||
Liabilities | Inputs | Inputs | |||||||||||||
Total | (Level 1) | (Level 2) | (Level 3) | ||||||||||||
Deferred compensation under | |||||||||||||||
executive employment agreements (1) | $ | 627,412 | - | - | $ | 627,412 | |||||||||
Note (1) $524,000 included in current liabilities and $103,412 included in long term liabilities on our consolidated condensed balance sheet as of March 31, 2013. | |||||||||||||||
Liabilities Measured On Recurring Basis, Unobservable Input Reconciliation | ' | ||||||||||||||
Fair Value Measurements Using Significant | |||||||||||||||
Unobservable Inputs (Level 3) | |||||||||||||||
Deferred Compensation Under Executive Employment Agreements | |||||||||||||||
Quarter Ended December 31, | Nine Months Ended December 31, | ||||||||||||||
2013 | 2012 | 2013 | 2012 | ||||||||||||
Balance at beginning of period | $ | 666,229 | $ | 602,081 | $ | 627,412 | $ | 715,107 | |||||||
Transfers into Level 3 | - | - | - | - | |||||||||||
Transfers out of Level 3 | - | - | - | - | |||||||||||
Total gains or losses (realized and unrealized): | |||||||||||||||
Included in earnings | 19,936 | 12,840 | 58,753 | 51,821 | |||||||||||
Included in other comprehensive income | - | - | - | - | |||||||||||
Settlements | -524,000 | - | -524,000 | -152,007 | |||||||||||
Balance at the end of period | $ | 162,165 | $ | 614,921 | $ | 162,165 | $ | 614,921 | |||||||
Loss for the quarter included in earnings attributable | |||||||||||||||
to the Level 3 liability still held at the end of the period | $ | 19,936 | $ | 12,840 | $ | 58,753 | $ | 51,821 | |||||||
Contracts_In_Process_Narrative
Contracts In Process (Narrative) (Details) | 9 Months Ended | 12 Months Ended |
Dec. 31, 2013 | Mar. 31, 2013 | |
Contracts In Process [Abstract] | ' | ' |
Estimated Period To Complete Contracts In Process, Minimum | '1 month | '1 month |
Estimated Period To Complete Contracts In Process, Maximum | '13 months | '1 year 9 months |
Expected collection period of accounts receivable | '60 days | ' |
Contracts_In_Process_Summary_O
Contracts In Process (Summary Of Contract In Process) (Details) (USD $) | Dec. 31, 2013 | Mar. 31, 2013 |
Contracts In Process [Abstract] | ' | ' |
Costs incurred on uncompleted contracts | $1,366,709 | $838,246 |
Estimated earnings | 636,517 | 515,299 |
Contracts in process, Gross | 2,003,226 | 1,353,545 |
Less billings to date | -1,558,189 | -1,175,281 |
Contracts in process | 445,037 | 178,264 |
Costs and estimated earnings in excess of billings on uncompleted contracts | $445,037 | $178,264 |
Inventories_Schedule_Of_Invent
Inventories (Schedule Of Inventories) (Details) (USD $) | Dec. 31, 2013 | Mar. 31, 2013 |
Inventories [Abstract] | ' | ' |
Raw materials | $7,697,141 | $8,097,342 |
Work-in-process | 126,976 | 356,696 |
Finished products | 2,430,957 | 2,544,423 |
Inventories, Total | $10,255,074 | $10,998,461 |
Facility_Held_For_Sale_Narrati
Facility Held For Sale (Narrative) (Details) (USD $) | 9 Months Ended |
Dec. 31, 2013 | |
Facility Held For Sale [Abstract] | ' |
Proceeds from sale of facility held for sale, Gross | $1,650,000 |
Cash proceeds from sale of facility held for sale | $1,565,032 |
Government_Grants_Narrative_De
Government Grants (Narrative) (Details) (USD $) | 9 Months Ended |
Dec. 31, 2013 | |
Government Grants [Abstract] | ' |
Government grant, approved funding | $32,400,000 |
Percentage of eligible costs reimbursed by government grants | 50.00% |
Threshold for government reimbursement, asset fair value | 5,000 |
Grant reimbursements received | 24,000,000 |
Grant funds receivable | 200,000 |
Change in Estimate of Reimbursable Rates | $958,000 |
Government_Grants_Schedule_Of_
Government Grants (Schedule Of Capital Asset Purchases, Partially Funded By Government Grants) (Details) (USD $) | Dec. 31, 2013 | Mar. 31, 2013 |
Government Grants [Line Items] | ' | ' |
Purchase Cost | $19,213,140 | $18,384,532 |
Grant Funding | 9,606,570 | 9,192,266 |
Recorded Value | 9,606,570 | 9,192,266 |
Land [Member] | ' | ' |
Government Grants [Line Items] | ' | ' |
Purchase Cost | 896,388 | 896,388 |
Grant Funding | 448,194 | 448,194 |
Recorded Value | 448,194 | 448,194 |
Building [Member] | ' | ' |
Government Grants [Line Items] | ' | ' |
Purchase Cost | 9,906,736 | 9,906,736 |
Grant Funding | 4,953,368 | 4,953,368 |
Recorded Value | 4,953,368 | 4,953,368 |
Machinery and equipment [Member] | ' | ' |
Government Grants [Line Items] | ' | ' |
Purchase Cost | 8,410,016 | 7,581,408 |
Grant Funding | 4,205,008 | 3,790,704 |
Recorded Value | $4,205,008 | $3,790,704 |
Other_Current_Liabilities_Sche
Other Current Liabilities (Schedule Of Other Current Liabilities) (Details) (USD $) | Dec. 31, 2013 | Mar. 31, 2013 |
Other Current Liabilities [Abstract] | ' | ' |
Accrued payroll and employee benefits | $64,024 | $174,135 |
Accrued personal property and real estate taxes | 313,243 | 264,814 |
Accrued warranty costs | 168,587 | 77,393 |
Unearned revenue | 60,512 | 71,442 |
Accrued royalties | 48,336 | 48,336 |
Accrued import duties | 87,100 | 813,740 |
Accrued Vendor Settlements | 916,809 | 1,050,000 |
Other | 7,503 | 99,575 |
Other current liabilities, Total | $1,666,114 | $2,599,435 |
Other_Current_Liabilities_Narr
Other Current Liabilities (Narrative) (Details) (USD $) | 9 Months Ended | |
Dec. 31, 2013 | Mar. 31, 2013 | |
Other Current Liabilities [Abstract] | ' | ' |
Accrued import duties | $87,100 | $813,740 |
Reduction of Accrued Import Duties | $726,640 | ' |
StockBased_Compensation_Narrat
Stock-Based Compensation (Narrative) (Details) (USD $) | 3 Months Ended | 9 Months Ended | ||
Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2013 | Dec. 31, 2012 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ' | ' | ' | ' |
Fair value of options vested in period | $9,333 | $77,058 | $493,271 | $885,916 |
Equity Incentive Plan [Member] | ' | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ' | ' | ' | ' |
Number of shares authorized | 1,100,000 | ' | 1,100,000 | ' |
Number of shares available for grant | 14,870 | ' | 14,870 | ' |
Plan term | ' | ' | '10 years | ' |
Award, expiration period | ' | ' | '10 years | ' |
Vesting period | ' | ' | '3 years | ' |
Maximum number of grants, per employee, per year | ' | ' | 500,000 | ' |
Cash received from settlement of share-based awards | 11,387 | ' | 11,387 | 0 |
Unrecognized compensation costs | 351,378 | ' | 351,378 | ' |
Unrecognized compensation costs, period for recognition | ' | ' | '17 years | ' |
Non-Employee Director Stock Option Plan [Member] | ' | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ' | ' | ' | ' |
Number of shares authorized | 1,000,000 | ' | 1,000,000 | ' |
Number of shares available for grant | 224,173 | ' | 224,173 | ' |
Non-Employee Director Stock Option Plan [Member] | Minimum [Member] | ' | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ' | ' | ' | ' |
Award, expiration period | ' | ' | '3 years | ' |
Non-Employee Director Stock Option Plan [Member] | Maximum [Member] | ' | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ' | ' | ' | ' |
Award, expiration period | ' | ' | '10 years | ' |
Stock Purchase Plan [Member] | ' | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ' | ' | ' | ' |
Number of shares authorized | 700,000 | ' | 700,000 | ' |
Number of shares available for grant | 321,539 | ' | 321,539 | ' |
Maximum percentage of base compensation that may be contributed to purchase shares of common stock | 10.00% | ' | 10.00% | ' |
Purchase of common stock under share-based compensation plan, percentage of fair market value | ' | ' | 85.00% | ' |
Shares issued in period for share-based awards | ' | ' | 48,532 | 85,336 |
Cash received from settlement of share-based awards | ' | ' | 39,438 | 75,178 |
Stock Bonus Plan [Member] | ' | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ' | ' | ' | ' |
Number of shares authorized | 1,954,994 | ' | 1,954,994 | ' |
Number of shares available for grant | 47,149 | ' | 47,149 | ' |
Unrecognized compensation costs | $571,609 | ' | $571,609 | ' |
Unrecognized compensation costs, period for recognition | ' | ' | '26 months | ' |
StockBased_Compensation_Schedu
Stock-Based Compensation (Schedule Of Share-Based Compensation Expense) (Details) (USD $) | 3 Months Ended | 9 Months Ended | ||
Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2013 | Dec. 31, 2012 | |
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] | ' | ' | ' | ' |
Share-based compensation expense | $172,640 | $220,063 | $610,716 | $1,020,740 |
Costs Of Contract Services [Member] | ' | ' | ' | ' |
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] | ' | ' | ' | ' |
Share-based compensation expense | 3,647 | 6,062 | 15,712 | 16,362 |
Costs Of Product Sales [Member] | ' | ' | ' | ' |
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] | ' | ' | ' | ' |
Share-based compensation expense | 10,565 | 13,492 | 30,883 | 35,329 |
Research And Development [Member] | ' | ' | ' | ' |
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] | ' | ' | ' | ' |
Share-based compensation expense | 4,282 | 846 | 7,544 | 2,152 |
Production Engineering [Member] | ' | ' | ' | ' |
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] | ' | ' | ' | ' |
Share-based compensation expense | 30,659 | 35,765 | 103,007 | 114,360 |
Selling, General And Administrative [Member] | ' | ' | ' | ' |
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] | ' | ' | ' | ' |
Share-based compensation expense | $123,487 | $163,898 | $453,570 | $852,537 |
StockBased_Compensation_Schedu1
Stock-Based Compensation (Schedule Of Nonvested Share Activity) (Details) (USD $) | 9 Months Ended | |
Dec. 31, 2013 | Dec. 31, 2012 | |
Equity Incentive Plan, Non-Vested Portion [Member] | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ' | ' |
Non-vested at Period Start, Weighted-Average Grant Date Fair Value | $0.84 | ' |
Granted, Weighted-Average Grant Date Fair Value | $0.68 | ' |
Vested Weighted-Average Grant Date Fair Value | $0.92 | ' |
Forfeited Weighted-Average Grant Date Fair Value | $0.84 | ' |
Non-vested at Period End, Weighted-Average Grant Date Fair Value | $0.75 | ' |
Non-vested at Period Start, Options | 1,152,828 | 668,722 |
Granted, Options | 89,340 | 1,418,792 |
Vested, Options | -533,380 | -888,089 |
Forfeited, Options | -12,262 | -38,810 |
Non-vested at Period End, Options | 696,526 | 1,160,615 |
Non-vested at Period Start, Options, Weighted-Average Grant Date Fair Value | ' | $1.69 |
Granted, Options, Weighted-Average Grant Date Fair Value | ' | $0.56 |
Vested, Options, Weighted-Average Grant Date Fair Value | ' | $1 |
Forfeited, Options, Weighted-Average Grant Date Fair Value | ' | $1.37 |
Non-vested at Period End, Options, Weighted-Average Grant Date Fair Value | ' | $0.84 |
Stock Bonus Plan [Member] | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ' | ' |
Non-vested at Period Start, shares | 358,855 | 167,680 |
Granted, shares | 452,195 | 454,866 |
Vested, shares | -166,231 | -263,691 |
Forfeited, shares | -3,840 | ' |
Non-vested at Period End, shares | 640,979 | 358,855 |
Non-vested at Period Start, Weighted-Average Grant Date Fair Value | $1.22 | $2.44 |
Granted, Weighted-Average Grant Date Fair Value | $1.18 | $0.87 |
Vested Weighted-Average Grant Date Fair Value | $1.34 | $1.39 |
Forfeited Weighted-Average Grant Date Fair Value | $1.25 | ' |
Non-vested at Period End, Weighted-Average Grant Date Fair Value | $1.17 | $1.22 |
StockBased_Compensation_Summar
Stock-Based Compensation (Summary Of Stock Option Activity) (Details) (USD $) | 9 Months Ended | 12 Months Ended | ||
Dec. 31, 2013 | Dec. 31, 2012 | Mar. 31, 2013 | Mar. 31, 2012 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ' | ' | ' | ' |
Outstanding at Period End, Options | 3,605,526 | 4,496,168 | ' | ' |
Outstanding, Weighted Average Remaining Contractual Life | '4 years 8 months 12 days | '4 years 9 months 18 days | '4 years 8 months 12 days | '3 years 10 months 24 days |
Exercisable, Weighted Average Remaining Contractual Life | '3 years 10 months 24 days | '3 years 3 months 18 days | ' | ' |
Vested and expected to vest, Weighted Average Remaining Contractual Life | '4 years 8 months 12 days | '4 years 8 months 12 days | ' | ' |
Equity Incentive Plan [Member] | ' | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ' | ' | ' | ' |
Outstanding at Period Start, Options | 4,251,695 | 3,228,210 | 3,228,210 | ' |
Granted, Options | 89,340 | 1,418,792 | ' | ' |
Exercised, Options | -12,794 | ' | ' | ' |
Forfeited, Options | -736,604 | -176,420 | ' | ' |
Outstanding at Period End, Options | 3,591,637 | 4,470,582 | ' | ' |
Exercisable, Options | 2,895,111 | 3,309,967 | ' | ' |
Vested and expected to vest, Options | 3,555,224 | 4,413,233 | ' | ' |
Outstanding at Period Start, Weighted-Average Exercise Price | 2.14 | 2.78 | 2.78 | ' |
Granted, Weighted-Average Exercise Price | 1.11 | 0.87 | ' | ' |
Exercised, Weighted-Average Exercise Price | 0.89 | ' | ' | ' |
Forfeited, Weighted-Average Exercise Price | 2.69 | 2.97 | ' | ' |
Outstanding at Period End, Weighted-Average Exercise Price | 2.01 | 2.17 | ' | ' |
Exercisable, Weighted-Average Exercise Price | 2.23 | 2.5 | ' | ' |
Vested and expected to vest, Weighted-Average Exercise Price | 2.02 | 2.18 | ' | ' |
Exercised, Aggregate Intrinsic Value | 15,689 | ' | ' | ' |
Outstanding at Period End, Aggregate Intrinsic Value | 1,859,201 | ' | ' | ' |
Exercisable, Aggregate Intrinsic Value | 1,102,526 | ' | ' | ' |
Vested and expected to vest, Aggregate Intrinsic Value | 1,818,171 | ' | ' | ' |
StockBased_Compensation_Stock_
Stock-Based Compensation (Stock Option Estimates) (Details) (USD $) | 3 Months Ended | 9 Months Ended | |
Dec. 31, 2012 | Dec. 31, 2013 | Dec. 31, 2012 | |
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract] | ' | ' | ' |
Weighted average estimated fair value of grant | $0.43 | $0.67 | $0.56 |
Expected life (in years) | '2 years 6 months | '4 years 9 months 18 days | '6 years 3 months 18 days |
Risk free interest rate | 0.73% | 2.30% | 1.30% |
Expected volatility | 81.85% | 73.91% | 72.80% |
Expected dividend yield | 0.00% | 0.00% | 0.00% |
Stockholders_Equity_Details
Stockholders' Equity (Details) (USD $) | 3 Months Ended | 9 Months Ended | ||||
Dec. 31, 2013 | Sep. 30, 2013 | Jun. 30, 2013 | Dec. 31, 2012 | Dec. 31, 2013 | Dec. 31, 2012 | |
Class of Stock [Line Items] | ' | ' | ' | ' | ' | ' |
Beginning balance, value | $23,895,725 | $24,014,613 | $24,764,671 | ' | $24,764,671 | ' |
Beginning balance, shares | 36,864,358 | 36,669,509 | 36,664,097 | ' | 36,664,097 | ' |
Issuance of common stock under employee stock purchase plan, value | 17,837 | 18,029 | 3,572 | ' | ' | ' |
Issuance of common stock under employee stock purchase plan, shares | 14,502 | 28,618 | 5,412 | ' | ' | ' |
Issuance of common stock under stock bonus plan, value | 11,387 | 36,499 | ' | ' | ' | ' |
Issuance of common stock under stock bonus plan, shares | 12,794 | 166,231 | ' | ' | ' | ' |
Compensation expense from employee and director stock option and common stock grants | 172,640 | 238,853 | 162,724 | ' | ' | ' |
Net loss | -65,913 | -412,269 | -916,354 | -4,555,033 | -1,394,536 | -8,406,015 |
Ending balance, value | 24,031,676 | 23,895,725 | 24,014,613 | ' | 24,031,676 | ' |
Ending balance, shares | 36,891,654 | 36,864,358 | 36,669,509 | ' | 36,891,654 | ' |
Common Stock [Member] | ' | ' | ' | ' | ' | ' |
Class of Stock [Line Items] | ' | ' | ' | ' | ' | ' |
Beginning balance, value | 368,644 | 366,695 | 366,641 | ' | 366,641 | ' |
Issuance of common stock under employee stock purchase plan, value | 145 | 286 | 54 | ' | ' | ' |
Issuance of common stock under stock bonus plan, value | 128 | 1,663 | ' | ' | ' | ' |
Ending balance, value | 368,917 | 368,644 | 366,695 | ' | 368,917 | ' |
Additional Paid-in Capital [Member] | ' | ' | ' | ' | ' | ' |
Class of Stock [Line Items] | ' | ' | ' | ' | ' | ' |
Beginning balance, value | 116,031,005 | 115,739,573 | 115,573,331 | ' | 115,573,331 | ' |
Issuance of common stock under employee stock purchase plan, value | 17,692 | 17,743 | 3,518 | ' | ' | ' |
Issuance of common stock under stock bonus plan, value | 11,259 | 34,836 | ' | ' | ' | ' |
Compensation expense from employee and director stock option and common stock grants | 172,640 | 238,853 | 162,724 | ' | ' | ' |
Ending balance, value | 116,232,596 | 116,031,005 | 115,739,573 | ' | 116,232,596 | ' |
Accumulated Deficit [Member] | ' | ' | ' | ' | ' | ' |
Class of Stock [Line Items] | ' | ' | ' | ' | ' | ' |
Beginning balance, value | -92,503,924 | -92,091,655 | -91,175,301 | ' | -91,175,301 | ' |
Net loss | -65,913 | -412,269 | -916,354 | ' | ' | ' |
Ending balance, value | ($92,569,837) | ($92,503,924) | ($92,091,655) | ' | ($92,569,837) | ' |
Significant_Customers_Details
Significant Customers (Details) (USD $) | 3 Months Ended | 9 Months Ended | 12 Months Ended | 3 Months Ended | 9 Months Ended | 3 Months Ended | 9 Months Ended | 12 Months Ended | |||||||
Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2013 | Dec. 31, 2012 | Mar. 31, 2013 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2013 | Mar. 31, 2013 | |
Customer_A [Member] | Customer_A [Member] | Customer_A [Member] | Customer_A [Member] | Customer_A [Member] | Customer B [Member] | Customer B [Member] | Customer B [Member] | Customer B [Member] | Customer C [Member] | Customer C [Member] | Customer C [Member] | Customer C [Member] | Customer C [Member] | Customer C [Member] | |
Accounts Receivable [Member] | Accounts Receivable [Member] | Accounts Receivable [Member] | |||||||||||||
Concentration Risk [Line Items] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Revenue from major customer, amount | $189,968 | $735,190 | $652,632 | $978,230 | ' | $208,929 | $31,370 | $268,623 | $62,740 | $214,898 | $235,564 | $649,681 | $856,150 | ' | ' |
Revenue from major customer, percentage | 9.00% | 38.00% | 11.00% | 18.00% | ' | 10.00% | 2.00% | 4.00% | 1.00% | 11.00% | 12.00% | 11.00% | 16.00% | ' | ' |
Concentration risk, percentage | ' | ' | ' | ' | 3.00% | ' | ' | ' | ' | ' | ' | ' | ' | 27.00% | 9.00% |
Loss_Per_Common_Share_Details
Loss Per Common Share (Details) | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2013 | Mar. 31, 2013 | Dec. 31, 2012 | Mar. 31, 2012 |
Outstanding Stock Awards [Member] | Outstanding Stock Awards [Member] | Outstanding Stock Awards [Member] | Outstanding Stock Awards [Member] | Stock Options, Out Of The Money [Member] | Stock Options, Out Of The Money [Member] | Stock Options, Out Of The Money [Member] | Stock Options, Out Of The Money [Member] | Stock Options, In The Money [Member] | Stock Options, In The Money [Member] | Stock Options, In The Money [Member] | Stock Options, In The Money [Member] | Stock Bonus Plan [Member] | Stock Bonus Plan [Member] | Stock Bonus Plan [Member] | Stock Bonus Plan [Member] | |||
Earnings (Loss) Per Common Share [Line Items] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Common shares issued under the Stock Bonus Plan | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 640,979 | 358,855 | 358,855 | 167,680 |
Antidilutive shares excluded from computation of diluted loss per share | ' | ' | 213,943 | 34,793 | 92,779 | 26,519 | 2,125,169 | 3,091,144 | 2,125,169 | 3,066,144 | 768,662 | 198,847 | 497,477 | 144,379 | ' | ' | ' | ' |
Outstanding, Options | 3,605,526 | 4,496,168 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Fair_Value_Measurements_Narrat
Fair Value Measurements (Narrative) (Details) (USD $) | 9 Months Ended |
Dec. 31, 2013 | |
Fair Value Inputs, Liabilities, Quantitative Information [Line Items] | ' |
Defined Benefit Plan, Effect of One Percentage Point Decrease on Accumulated Postretirement Benefit Obligation | $2,000 |
Significant Unobservable Inputs (Level 3) [Member] | ' |
Fair Value Inputs, Liabilities, Quantitative Information [Line Items] | ' |
Fair Value Inputs, Discount Rate | 14.00% |
Fair_Value_Measurements_Liabil
Fair Value Measurements (Liabilities Measured At Fair Value On A Recurring Basis) (Details) (USD $) | Dec. 31, 2013 | Mar. 31, 2013 | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | |
Deferred compensation under executive employment agreements | $162,165 | $627,412 | [1] |
Significant Unobservable Inputs (Level 3) [Member] | ' | ' | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | |
Deferred compensation under executive employment agreements | $162,165 | $627,412 | [1] |
[1] | $524,000 included in current liabilities and $103,412 included in long term liabilities on our consolidated condensed balance sheet as of March 31, 2013. |
Fair_Value_Measurements_Liabil1
Fair Value Measurements (Liabilities Measured On Recurring Basis, Unobservable Input Reconciliation) (Details) (USD $) | 3 Months Ended | 9 Months Ended | ||
Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2013 | Dec. 31, 2012 | |
Fair Value Measurements [Abstract] | ' | ' | ' | ' |
Balance at beginning of quarter | $666,229 | $602,081 | $627,412 | $715,107 |
Transfers into Level 3 | ' | ' | ' | ' |
Transfers out of Level 3 | ' | ' | ' | ' |
Total gains or losses included in earnings | 19,936 | 12,840 | 58,753 | 51,821 |
Total gains or losses included in other comprehensive income | ' | ' | ' | ' |
Settlements | -524,000 | ' | -524,000 | -152,007 |
Balance at the end of quarter | $162,165 | $614,921 | $162,165 | $614,921 |
Commitments_And_Contingencies_
Commitments And Contingencies (Details) (USD $) | Dec. 31, 2013 | Mar. 31, 2013 |
Commitments And Contingencies [Abstract] | ' | ' |
Aggregate future base salary payable | $1,908,167 | ' |
Potential future compensation payable | $162,165 | $627,412 |